Rhonda Lynette Hellums
CIK: 0001766456
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SLN
Silence Therapeutics plc
DirectorOfficer
Discretionary Trading P&L
Holdings
About HELLUMS RHONDA LYNETTE
HELLUMS RHONDA LYNETTE (SEC CIK 0001766456) files insider reports with the SEC as Chief Financial Officer of Silence Therapeutics plc (SLN).
Signal8 holds 3 ownership filings by HELLUMS RHONDA LYNETTE (1 Form 3, 2 Form 4), filed between Jan 2, 2025 and Jan 6, 2026. Those filings report 2 transactions, from Jan 2, 2025 to Jan 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on HELLUMS RHONDA LYNETTE's filings is in LONDON, X0.
Recent filings by HELLUMS RHONDA LYNETTE
Other insiders filing for Silence Therapeutics plc (SLN)
- Griffiths Richard Ian, 10% Owner
- Ede-Golightly James, Director
- MCINERNEY TIMOTHY, Director
- Romano Steven J., EVP and Chief R&D Officer
- Lemus David, Director
- Ross Iain, Director